ADMA BIOLOGICS INC (ADMA:NASDAQ)
$10.36 0.03 (0.2904%)
Analysed ADMA BIOLOGICS INC (ADMA:NASDAQ) News Sources
Adma Biologics (ADMA) Down 4.8% Since Last Earnings Report: Can It Rebound?
04-09-2026
yahoo.com
Adma Biologics (ADMA) Is Considered a Good Investment by Brokers: Is That True?
08-09-2026
yahoo.com
Adma Biologics (ADMA) Falls More Steeply Than Broader Market: What Investors Need to Know
10-09-2026
yahoo.com
Adma Biologics (ADMA) Stock Falls Amid Market Uptick: What Investors Need to Know
11-09-2026
yahoo.com
Adma Biologics (ADMA) Outpaces Stock Market Gains: What You Should Know
18-09-2026
yahoo.com
Wall Street Analysts Think Adma Biologics (ADMA) Is a Good Investment: Is It?
24-09-2026
yahoo.com
Why Adma Biologics (ADMA) Dipped More Than Broader Market Today
24-09-2026
yahoo.com
ADMA Biologics (ADMA), Why Is It Back In The Spotlight?
27-09-2026
yahoo.com
ADMA Biologics Inc (ADMA) is Attracting Investor Attention: Here is What You Should Know
08-10-2026
yahoo.com
Adma Biologics (ADMA) Advances While Market Declines: Some Information for Investors
08-10-2026
yahoo.com
What is the current price of ADMA BIOLOGICS INC (ADMA:NASDAQ)?
The current price of ADMA BIOLOGICS INC (ADMA:NASDAQ) is $10.36.
ADMA BIOLOGICS INC (ADMA:NASDAQ) absolute price change since previous trading day?
The absolute price change of ADMA BIOLOGICS INC (ADMA:NASDAQ) since the previous trading day is $0.03.
ADMA BIOLOGICS INC (ADMA:NASDAQ) percentage price change since previous trading day?
The percentage price change of ADMA BIOLOGICS INC (ADMA:NASDAQ) since the previous trading day is 0.2904%.
What is the most recent average sentiment score for ADMA BIOLOGICS INC (ADMA:NASDAQ)?
The most recent average sentiment score for ADMA BIOLOGICS INC (ADMA:NASDAQ) is 61 out of 100.
What is the most recent average sentiment for ADMA BIOLOGICS INC (ADMA:NASDAQ)?
The most recent sentiment for ADMA BIOLOGICS INC (ADMA:NASDAQ) is .
SEC-8K** Filing Available For ADMA BIOLOGICS INC (ADMA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.